Cargando…
Current status and future directions in the management of chronic hepatitis C
Hepatitis C virus (HCV) is endemic worldwide, and it causes cirrhosis and other complications that often lead to death; nevertheless, our knowledge of the disease and its mechanisms is limited. HCV is most common in underdeveloped nations, including many in Africa and Asia. The virus is usually tran...
Autores principales: | Aman, Wosen, Mousa, Shaymaa, Shiha, Gamal, Mousa, Shaker A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325870/ https://www.ncbi.nlm.nih.gov/pubmed/22385500 http://dx.doi.org/10.1186/1743-422X-9-57 |
Ejemplares similares
-
Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy
por: Lin, Yun, et al.
Publicado: (2010) -
Novel combined single dose anti-hepatitis C therapy: a pilot study
por: Shiha, Gamal, et al.
Publicado: (2021) -
Addition of Epigallocatechin Gallate 400 mg to Sofosbuvir 400 mg + Daclatisvir 60 mg With or Without Ribavirin in Treatment of Patients with Chronic Hepatitis C Improves the Safety Profile: A Pilot Study
por: Shiha, Gamal, et al.
Publicado: (2019) -
Current primary open-angle glaucoma treatments and future directions
por: Beidoe, Gabriel, et al.
Publicado: (2012) -
Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
por: Avery, Peter, et al.
Publicado: (2009)